Annual long term liabilities:
$281.38M+$22.97M(+8.89%)Summary
- As of today (May 30, 2025), AXSM annual total long term liabilities is $281.38 million, with the most recent change of +$22.97 million (+8.89%) on December 31, 2024.
- During the last 3 years, AXSM annual long term liabilities has risen by +$232.29 million (+473.20%).
- AXSM annual long term liabilities is now at all-time high.
Performance
AXSM Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$299.55M+$18.17M(+6.46%)Summary
- As of today (May 30, 2025), AXSM quarterly total long term liabilities is $299.55 million, with the most recent change of +$18.17 million (+6.46%) on March 31, 2025.
- Over the past year, AXSM quarterly long term liabilities has increased by +$41.91 million (+16.27%).
- AXSM quarterly long term liabilities is now at all-time high.
Performance
AXSM quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AXSM Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.9% | +16.3% |
| 3 y3 years | +473.2% | +507.4% |
| 5 y5 years | +1523.4% | +1827.1% |
AXSM Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +473.2% | at high | +507.4% |
| 5 y | 5-year | at high | +1523.4% | at high | +2079.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
AXSM Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $299.55M(+6.5%) |
| Dec 2024 | $281.38M(+8.9%) | $281.38M(+3.3%) |
| Sep 2024 | - | $272.37M(+5.2%) |
| Jun 2024 | - | $258.80M(+0.5%) |
| Mar 2024 | - | $257.64M(-0.3%) |
| Dec 2023 | $258.40M(+106.1%) | $258.40M(+19.3%) |
| Sep 2023 | - | $216.69M(-0.5%) |
| Jun 2023 | - | $217.86M(+23.3%) |
| Mar 2023 | - | $176.72M(+41.0%) |
| Dec 2022 | $125.36M(+155.4%) | $125.36M(+3.3%) |
| Sep 2022 | - | $121.31M(-1.2%) |
| Jun 2022 | - | $122.79M(+149.0%) |
| Mar 2022 | - | $49.31M(+0.5%) |
| Dec 2021 | $49.09M(+0.4%) | $49.09M(-0.2%) |
| Sep 2021 | - | $49.17M(+0.4%) |
| Jun 2021 | - | $48.96M(+0.1%) |
| Mar 2021 | - | $48.93M(+0.0%) |
| Dec 2020 | $48.90M(+182.1%) | $48.90M(+1.8%) |
| Sep 2020 | - | $48.03M(+249.4%) |
| Jun 2020 | - | $13.74M(-11.6%) |
| Mar 2020 | - | $15.54M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $17.33M(+378.9%) | $17.33M(-9.3%) |
| Sep 2019 | - | $19.11M(+9.7%) |
| Jun 2019 | - | $17.42M(-7.4%) |
| Mar 2019 | - | $18.82M(+419.9%) |
| Dec 2018 | $3.62M(-45.7%) | $3.62M(-18.5%) |
| Sep 2018 | - | $4.44M(-14.5%) |
| Jun 2018 | - | $5.19M(-12.5%) |
| Mar 2018 | - | $5.93M(-11.0%) |
| Dec 2017 | $6.66M(-29.6%) | $6.66M(-9.7%) |
| Sep 2017 | - | $7.38M(-8.7%) |
| Jun 2017 | - | $8.08M(-8.0%) |
| Mar 2017 | - | $8.78M(-7.3%) |
| Dec 2016 | $9.47M(>+9900.0%) | $9.47M(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $12.56M(+150.3%) |
| Dec 2014 | $5.02M(>+9900.0%) | $5.02M |
| Dec 2013 | $0.00 | - |
FAQ
- What is Axsome Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics annual long term liabilities year-on-year change?
- What is Axsome Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly long term liabilities year-on-year change?
What is Axsome Therapeutics annual total long term liabilities?
The current annual long term liabilities of AXSM is $281.38M
What is the all time high annual long term liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high annual total long term liabilities is $281.38M
What is Axsome Therapeutics annual long term liabilities year-on-year change?
Over the past year, AXSM annual total long term liabilities has changed by +$22.97M (+8.89%)
What is Axsome Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of AXSM is $299.55M
What is the all time high quarterly long term liabilities for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly total long term liabilities is $299.55M
What is Axsome Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, AXSM quarterly total long term liabilities has changed by +$41.91M (+16.27%)